Keywords: USA, New drug approvals, FDA, Burrill & Co

New US drug approvals in 2011 already match 2010 total

Article | 02 August 2011

The July approval of AstraZeneca’s blood-thinner Brilinta (ticagrelor), a potential blockbuster that will compete against Sanofi/Bristol-Myers Squibb& ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in